Federica Piccioni

Broad Institute — United States

Biochemistry, Genetics and Molecular Biology · Life Sciences

46h-index12.0kcitations357works2.22yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Fibroblast Growth Factor Research(48), Protein Degradation and Inhibitors(43), Cancer Genomics and Diagnostics(39), CRISPR and Genetic Engineering(38), Ovarian cancer diagnosis and treatment(32)

Publications357 total

Supplementary Figures and Tables from A Ubiquitination Cascade Regulating the Integrated Stress Response and Survival in Carcinomas
2025Open Access
Supplementary Tables from An <i>In Vivo</i> CRISPR Screening Platform for Prioritizing Therapeutic Targets in AML
2025Open Access
Supplementary Data from An <i>In Vivo</i> CRISPR Screening Platform for Prioritizing Therapeutic Targets in AML
2025Open Access
Supplementary Figures from An <i>In Vivo</i> CRISPR Screening Platform for Prioritizing Therapeutic Targets in AML
2025Open Access
Supplementary Table S3 from Transcriptional Antagonism by CDK8 Inhibition Improves Therapeutic Efficacy of MEK Inhibitors
2025Open Access
Supplemental Figures and Legends from Transcriptional Antagonism by CDK8 Inhibition Improves Therapeutic Efficacy of MEK Inhibitors
2025Open Access
Supplementary Table S1 from Transcriptional Antagonism by CDK8 Inhibition Improves Therapeutic Efficacy of MEK Inhibitors
2025Open Access
Supplementary Table S2 from Transcriptional Antagonism by CDK8 Inhibition Improves Therapeutic Efficacy of MEK Inhibitors
2025Open Access
<i>In vitro</i> models of cancer‐associated fibroblast heterogeneity uncover subtype‐specific effects of <scp>CRISPR</scp> perturbations
Molecular Oncology·2025Open Access
SPACE: multimodal spatial CRISPR screening with whole-transcriptome readout at subcellular resolution in 3D models
2025· 2 citedOpen Access
Abstract LB318: MYC primes a paralog synthetic lethality involving the mitochondrial transporters TIMM17A and TIMM17B and N-acetylaspartate
Cancer Research·2025
Editorial Expression of Concern: A melanocyte lineage program confers resistance to MAP kinase pathway inhibition
Nature·2025Open Access
Abstract 986: <i>SMARCB1</i> missense mutants destabilize SWI/SNF complex stability and remodeling activity
Cancer Research·2025
SMARCB1 missense mutants disrupt SWI/SNF complex stability and remodeling activity
2025· 1 citedOpen Access
Functional screening reveals genetic dependencies and diverging cell cycle control in atypical teratoid rhabdoid tumors
Genome biology·2024· 5 citedOpen Access
Abstract B009: Characterization and CRISPR perturbation of cancer-associated fibroblast heterogeneity <i>in vitro</i> models
Cancer Research·2024
Abstract B028: Deep mutational scanning of SMARCB1 identifies missense mutants that destabilize SWI/SNF complex stability and diminish remodeling activity
Cancer Research·2024
Genome-wide CRISPR-Cas9 knockout screens identify DNMT1 as a druggable dependency in sonic hedgehog medulloblastoma
Acta Neuropathologica Communications·2024· 9 citedOpen Access
TYK2 as a novel therapeutic target in Alzheimer’s Disease with TDP-43 inclusions
2024· 4 citedOpen Access
Author Correction: Comprehensive mutational scanning of EGFR reveals TKI sensitivities of extracellular domain mutants
Nature Communications·2024· 1 citedOpen Access
page 1 of 18Next →

Frequent Co-authors

David E. Root(31), William C. Hahn(14), John G. Doench(13), Amy Goodale(13), Cory M. Johannessen(10), Mukta Bagul(9), Jesse S. Boehm(9), Todd R. Golub(9), Francisca Vázquez(8), Matthew Meyerson(8), Xiaoping Yang(7), Kimberly Stegmaier(7), Nathanael S. Gray(6), Xiaoyun Wu(6), Levi A. Garraway(6), Sasha Pantel(6), Aravind Subramanian(5), Gad Getz(5), Steven A. Carr(5), Ofir Cohen(5)